GlassScriptPhysician profile
Douglas Thornton
NPI 1780071571
$675.86
in general payments reported to CMS, 2019-2025
11 companies · $14.61 in 2025
The $14.61 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $13.92 · 2021: $90.57 · 2022: $98.50 · 2023: $173 · 2024: $15.36 · 2025: $14.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $154.94 | 2023-2024 | Signia, Ligasure |
| Becton, Dickinson and Company | $129.83 | 2019 | |
| Braintree Laboratories, INC. | $128.24 | 2020-2023 | Sutab |
| Osiris Therapeutics INC. | $123.25 | 2019 | |
| Stryker Corporation | $38.89 | 2022 | |
| Depuy Synthes Sales INC. | $19.05 | 2021 | |
| Kerecis Limited | $17.41 | 2022 | |
| Tela Bio, INC. | $17.19 | 2019 | |
| Organogenesis INC. | $16.81 | 2023 | Puraply |
| Myriad Genetic Laboratories, INC. | $15.64 | 2022 | |
| Ethicon US, LLC | $14.61 | 2025 | N/A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Thornton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.